SBH
GSK icon

Segall Bryant & Hamill’s GSK GSK Stock Holding History

Segall Bryant & Hamill’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,906
Closed -$224K – 553
2014
Q3 		$224K Buy
3,906
+298
+8% +$18.3K 0.01% 524
2014
Q2 		$241K Sell
3,608
-1,020
-22% -$69K 0.01% 523
2014
Q1 		$309K Sell
4,628
-560
-11% -$37.9K 0.01% 511
2013
Q4 		$346K Sell
5,188
-194
-4% -$12.6K 0.01% 495
2013
Q3 		$337K Buy
5,382
+400
+8% +$25.7K 0.01% 494
2013
Q2 		$311K Buy
+4,982
New +$316K 0.01% 472

Other funds holding GSK

LTI
Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Segall Bryant & Hamill's GSK Position: Q4 2014 in Review

Segall Bryant & Hamill sold out of GSK (GSK) in Q4 2014, closing a stake of 3,906 shares — an estimated $224K sold.

Segall Bryant & Hamill first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $346K in Q4 2013. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Segall Bryant & Hamill reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
  • Segall Bryant & Hamill sold 3,906 GSK shares in Q4 2014, an estimated $224K.
  • Segall Bryant & Hamill first reported a position in GSK in Q2 2013 and held it in 6 quarters.
  • Segall Bryant & Hamill's GSK position peaked at $346K in Q4 2013.
  • 728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Segall Bryant & Hamill's 13F filing for Q4 2014, filed 12 Feb 2015.